GBI MEDILISTEN

Media Monitoring & Intelligence Platform for Pharma

GBI MEDILISTEN is a media intelligence platform built for the pharmaceutical industry, combining four core capabilities: real-time global monitoring, AI-powered bilingual analysis, curated daily briefings, and structured topic reports. Operating 24/7, it tracks policy, clinical, and commercial developments across key pharmaceutical markets. Users can switch instantly between Chinese and English, receive curated daily updates, and access structured reports that organize fragmented information into actionable insights to support strategic planning and investment decisions.

Request a Trial

Business Pain Points

Pain Point 1：Information Overload

The volume of pharmaceutical news and market developments continues to grow, making it difficult to identify the information that matters most amid the noise.

Pain Point 2：Language Barriers to Global Intelligence

Monitoring information across multiple languages is time-consuming and resource-intensive, limiting timely access to critical developments across global markets.

Pain Point 3：Turning Information into Actionable Insights

Daily news and market updates are often fragmented and difficult to synthesize, making it challenging to extract meaningful insights that support strategic decision-making.

Pain Point 4：Limited Long-Term Knowledge Management

Without a structured way to organize and preserve historical intelligence, tracking long-term trends and building institutional knowledge becomes increasingly difficult.

Solutions

GBI MEDILISTEN addresses the key challenges of pharmaceutical media intelligence by bringing together four integrated capabilities—from real-time monitoring and bilingual content to curated daily briefings and in-depth analysis. The platform helps pharmaceutical companies respond more quickly to emerging developments and make better-informed strategic decisions.

Solutions

01.Global Real-Time Monitoring

Monitor policy, clinical, and commercial developments across major pharmaceutical markets, including the China, US, Europe, and Japan. Continuous 24/7 monitoring helps users quickly identify high-value intelligence as it emerges.

02.Bilingual Content

Instantly switch between English and Chinese to overcome language barriers and enable more effective collaboration across global teams.

03.Daily News Briefings

Receive curated daily news briefings delivered directly to your inbox, keeping teams informed of the latest pharmaceutical developments without the need for constant monitoring.

04.Structured Thematic Reports

Transform fragmented news and market developments into structured thematic reports that provide a clearer view of emerging trends and support long-term strategic planning.

See the Whole Landscape Shape What's Next in Pharma

GBI Health unites global pharmaceutical data, AI capabilities and industry expertise to deliver future-ready solutions across the entire product lifecycle.